Henry H Chang
About Henry H Chang
Henry H Chang is a Scientist II at Bristol-Myers Squibb and Celgene, with extensive experience in translational oncology research and a strong background in both academic and industry environments.
Title
Henry H Chang holds the title of Scientist II.
Current Positions
Henry H Chang is currently employed as a Scientist II at both Bristol-Myers Squibb and Celgene in New Jersey, United States.
Previous Work Experience
Henry H Chang has held multiple positions in the pharmaceutical and biomedical research industries. He worked as a Senior Scientist and Scientist at Silver Creek Pharmaceuticals, Inc. in San Francisco, California. He was also a Senior Scientist at Newomics, and a Presidential Postdoctoral Fellow at the Novartis Institutes for Biomedical Research. Additionally, he served as a Howard Hughes Medical Institute Postdoctoral Fellow at UCSF.
Education and Expertise
Henry H Chang earned a Doctor of Philosophy in Philosophy and Chemistry from the University of California, Berkeley, where he was a Ph.D. Candidate. He also holds a Bachelor of Arts in Chemistry from Occidental College. Henry H Chang has extensive experience in translational research, particularly in oncology, and possesses expertise in the application of mass spectrometry for biomarker discovery.
Contributions and Achievements
Henry H Chang has contributed to multiple peer-reviewed publications in high-impact scientific journals. He played a key role in developing novel therapeutic strategies at Silver Creek Pharmaceuticals and has received multiple research grants and awards. He is actively involved in mentoring junior scientists and researchers.